World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
46
Citations
7681
World Ranking
16045
National Ranking
132

Serge Mignani publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Serge Mignani sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 259 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Serge Mignani D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Serge Mignani sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 46 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Serge Mignani is affiliated with Universidade da Madeira in Portugal. Their research spans multiple disciplines including biochemistry, genetics and molecular biology, and materials science. Within these domains, their work primarily focuses on molecular biology, polymers and plastics, biomedical engineering, organic chemistry, and biomaterials.

The main topics of investigation in Mignani's research include:

  • Dendrimers and Hyperbranched Polymers
  • RNA Interference and Gene Delivery
  • Advanced biosensing and bioanalysis techniques
  • Nanoplatforms for cancer theranostics
  • Chemical Synthesis and Analysis
  • Nanoparticle-Based Drug Delivery
  • Extracellular vesicles in disease

Several recent publications reflect the scope of their work. Notable papers include:

  • "hERG toxicity assessment: Useful guidelines for drug design" (2020), European Journal of Medicinal Chemistry
  • "Superstructured poly(amidoamine) dendrimer-based nanoconstructs as platforms for cancer nanomedicine: A concise review" (2020), Coordination Chemistry Reviews
  • "Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs" (2020), European Journal of Medicinal Chemistry
  • "Revisiting Cationic Phosphorus Dendrimers as a Nonviral Vector for Optimized Gene Delivery Toward Cancer Therapy Applications" (2020), Biomacromolecules
  • "Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis" (2020), Bioconjugate Chemistry

Mignani frequently collaborates with several co-authors, notably Jean-Pierre Majoral, Xiangyang Shi, Mingwu Shen, Mengsi Zhan, and Huxiao Sun. These collaborations have contributed significantly to their research output.

Their publications appear predominantly in scientific journals such as Biomacromolecules, European Journal of Medicinal Chemistry, ACS Nano, Drug Discovery Today, and Nano Today, indicating a consistent presence in venues relevant to both chemistry and nanomedicine.

Best Publications

  • Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy

    Yong Hu;Serge Mignani;Jean-Pierre Majoral;Mingwu Shen

  • Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.

    Serge Mignani;Saïd El Kazzouli;Mosto Bousmina;Jean-Pierre Majoral

  • Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines.

    Jimonet P;Audiau F;Barreau M;Blanchard Jc

  • hERG toxicity assessment: Useful guidelines for drug design.

    Amanda Garrido;Alban Lepailleur;Serge M. Mignani;Patrick Dallemagne

  • Dendrimers in combination with natural products and analogues as anti-cancer agents

    Serge M. Mignani;João C. Rodrigues;João C. Rodrigues;H. Tomás;Maria Zabłocka

  • From PtCl2‐ and Acid‐Catalyzed to Uncatalyzed Cycloisomerization of 2‐Propargyl Anilines: Access to Functionalized Indoles

    Kevin Cariou;Baptiste Ronan;Serge Mignani;Louis Fensterbank

  • Advances in Combination Therapies Based on Nanoparticles for Efficacious Cancer Treatment: An Analytical Report

    Serge Mignani;Maria Bryszewska;Barbara Klajnert-Maculewicz;Maria Zablocka

  • Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry

    Serge Mignani;Saïd El Kazzouli;Mosto Bousmina;Jean-Pierre Majoral

  • Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

    Cédric Lecoutey;Damien Hedou;Thomas Freret;Patrizia Giannoni

  • Poly(amidoamine) Dendrimer-Coordinated Copper(II) Complexes as a Theranostic Nanoplatform for the Radiotherapy-Enhanced Magnetic Resonance Imaging and Chemotherapy of Tumors and Tumor Metastasis

    Yu Fan;Jiulong Zhang;Menghan Shi;Dan Li

  • Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy

    Mengen Zhang;Jingyi Zhu;Yun Zheng;Rui Guo

  • Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?

    Serge Mignani;Serge Mignani;Serge Mignani;João Rodrigues;João Rodrigues;Helena Tomas;Rachid Jalal

  • Construction of polydopamine-coated gold nanostars for CT imaging and enhanced photothermal therapy of tumors: an innovative theranostic strategy

    Du Li;Yongxing Zhang;Shihui Wen;Yang Song

  • Stereocontrolled cyclopentenone synthesis via cycloaddition

    Barry M. Trost;Peter Seoane;Serge Mignani;Murat Acemoglu

  • Original multivalent copper(II)-conjugated phosphorus dendrimers and corresponding mononuclear copper(II) complexes with antitumoral activities.

    Nabil El Brahmi;Saïd El Kazzouli;Serge M Mignani;El Mokhtar Essassi

  • Dendrimer Space Exploration: An Assessment of Dendrimers/Dendritic Scaffolding as Inhibitors of Protein–Protein Interactions, a Potential New Area of Pharmaceutical Development

    Serge Mignani;Saïd El Kazzouli;Mosto M. Bousmina;Jean-Pierre Majoral

  • Why and how have drug discovery strategies in pharma changed? What are the new mindsets?

    Serge Mignani;Scot Huber;Helena Tomás;João Rodrigues

  • Enhanced Delivery of Therapeutic siRNA into Glioblastoma Cells Using Dendrimer-Entrapped Gold Nanoparticles Conjugated with β-Cyclodextrin

    Jieru Qiu;Lingdan Kong;Xueyan Cao;Aijun Li

  • Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis

    Unknown

  • Anticancer copper(II) phosphorus dendrimers are potent proapoptotic Bax activators

    Serge Mignani;Nabil El Brahmi;Laure Eloy;Joel Poupon

  • Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (B). Efficiency of pharmacological action

    Volha Dzmitruk;Aleksandra Szulc;Dzmitry Shcharbin;Anna Janaszewska

Frequent Co-Authors

Anne-Marie Caminade
Anne-Marie Caminade Centre national de la recherche scientifique, CNRS
Xiangyang Shi
Xiangyang Shi Donghua University
Jean-Pierre Majoral
Jean-Pierre Majoral Centre national de la recherche scientifique, CNRS
Maria Bryszewska
Maria Bryszewska University of Łódź
Mingwu Shen
Mingwu Shen Donghua University
Barry M. Trost
Barry M. Trost Stanford University
Janine Cossy
Janine Cossy ESPCI Paris
Pierre Casellas
Pierre Casellas Sanofi (France)
Valentín Ceña
Valentín Ceña University of Castilla-La Mancha
Mosto Bousmina
Mosto Bousmina Université Laval

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens the door to a variety of rewarding career paths, many of which can be pursued through specialized online degrees. For those interested in the pharmaceutical field, becoming a drug rep salary reflects a promising career with strong market demand, blending scientific knowledge with interpersonal skills.

Alternatively, pursuing a career as a pharmacist requires in-depth education but offers competitive earnings and job stability. To learn more about a career in this area, check out the guide on how to become a pharmacist salary.

Forensic science is another related field that chemistry graduates often explore. Online programs provide flexible options to earn a forensic science degree online, equipping students with skills applicable to legal and criminal investigations.

Those interested in the biological side of chemistry might consider becoming an autopsy technician. This role requires specialized training, and you can find more details about the path, education, and salary at autopsy technician.

Best Scientists Citing Serge Mignani

Trending Scientists

Recently Published Articles